Oligopeptide, angiotensin converting enzyme inhibitors, hypotens

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514 17, 530329, 530330, 530331, A61K 3702, C07K 506, C07K 508, C07K 706

Patent

active

052389219

ABSTRACT:
L-Tyr-L-Val, L-Leu-L-Tyr, L-Leu-L-Pro, L-Phe-L-Tyr, L-Tyr-L-Arg and its acid addition salts, L-Leu-L-Ser-L-Pro, L-Leu-L-Gln-L-Pro, L-Phe-L-Leu-L-Pro, L-Leu-L-Leu-L-Pro, L-Leu-L-Asn-L-Pro, L-Phe-L-Pro, L-Leu-L-Ala-L-Ala, L-Val-L-Ala-L-Ala, L-Leu-L-Gln-L-Gln, L-Val-L-Ala-L-Tyr, L-Leu-L-Ala-L-Tyr, L-Leu-L-Ser-L-His and its acid solution salts, L-Ile-L-Arg-L-Ala and its acid addition salts, L-Leu-L-Arg-L-Pro and its acid addition salts, and L-Ile-L-Arg-L-Ala-L-Gln-L-Gln and its acid addition salts, derived from a corn protein .alpha.-zein, and tripeptides represented by the formula

REFERENCES:
patent: Re29732 (1978-08-01), Flouret
patent: 4305872 (1981-12-01), Johnston et al.
patent: 4780528 (1988-10-01), Takemoto et al.
patent: 4900658 (1990-02-01), Konig et al.
patent: 5008246 (1991-04-01), Schon et al.
patent: 5041535 (1991-08-01), Nyeki et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Oligopeptide, angiotensin converting enzyme inhibitors, hypotens does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oligopeptide, angiotensin converting enzyme inhibitors, hypotens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligopeptide, angiotensin converting enzyme inhibitors, hypotens will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-829229

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.